Faculty profile

Danielle Rodin

ResearcherInstitute of Health Policy, Management and EvaluationUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Danielle Rodin

Researcher

Institute of Health Policy, Management and Evaluation

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
58 publications in the last five years, latest in 2026.
Senior (last) author on 18 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

105

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Breast Cancer Caregiving Costs Equity Financial Toxicity Gender Equity Global Health Health Economics Health Financing

Latest papers

Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.
Leukemia & lymphoma · 2026 · senior author
Pilot Health Care Provider Education Program for BRCA1/2 Genetic Testing, Counseling, and Management in Nigeria.
JCO global oncology · 2026
Management and Outcomes for Patients With Hodgkin Lymphoma With Partial Metabolic Response After First-Line Systemic Therapy.
Practical radiation oncology · 2026

All 105 publications

Latest funding

THE ACTION STUDY: Addressing global inequities in breast cancer genetic testing, counselling, and management in Nigeria
CIHR · 2026 · Co-investigator
$742,050
The ACTION Study: Addressing global inequities in breast cancer genetic testing, counselling, and management in Nigeria
CIHR · 2025 · Co-investigator
$100,000
Accounting for equity and economic burden in priority setting for breast cancer control in India
CIHR · 2022 · Principal investigator
$100,000

All 9 grants and awards

105 publications.

Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.

Gong IY, Rafinejad-Farahani B, Majeed H, Soto MJ, Oza A, Ehrlich T, Fernandez Lynch H, Guerra CE, Lofters A, Unger JM, Conti RM, Rosenthal M, Rodin D

Leukemia & lymphoma2026Senior author

DOI: 10.1080/10428194.2025.2579735 PMID: 41178673

Pilot Health Care Provider Education Program for BRCA1/2 Genetic Testing, Counseling, and Management in Nigeria.

Wuraola FO, Ramruthan J, Reel E, Peck L, Thain E, Kerrigan C, Santiago AT, Dare A, Covelli A, McCuaig J, Papadakos J, Rodin D, Jacobson M, Kingham PT, Mango VL, Alatise OI, Cil TD

JCO global oncology2026

DOI: 10.1200/go-25-00306 PMID: 41538750

Management and Outcomes for Patients With Hodgkin Lymphoma With Partial Metabolic Response After First-Line Systemic Therapy.

Liao D, Aminilari M, Ye XY, Metser U, Singnurkar A, Bhella S, Crump M, Kridel R, Kukreti V, Kuruvilla J, Prica A, Vijenthira A, Cheung M, Rodin D, Tsao M, Hodgson D

Practical radiation oncology2026

DOI: 10.1016/j.prro.2026.01.017 PMID: 41765363

Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.

Gong IY, Xiao NM, Chen C, Bhella S, Hueniken K, Marinoni M, Azab M, Aoki T, Kridel R, Kukreti V, Vijenthira A, Yang C, Rodin D, Jeeva M, Aminilari M, Malik N, Wells W, Hodgson D, Crump M, Prica A, Kuruvilla J

Leukemia & lymphoma2026

DOI: 10.1080/10428194.2026.2682290 PMID: 42295978

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

Abeyakoon C, Wellard C, Murad V, Chung E, Hodgson D, Rodin D, Prica A, Aoki T, Vijenthira A, Falcone U, Opat S, Wood EM, McQuilten ZK, Hawkes EA, Crump M, Kuruvilla J, Gregory GP

British journal of haematology2026

DOI: 10.1111/bjh.70689 PMID: 42469158

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

Ruicci KM, Helou J, Barry A, Ye XY, Koch CA, Croke J, Han K, Rodin D, Hahn E, Kwan JYY, Yan M, Liu FF, Lindsay P, Javor J, Bedard P, Cescon D, Kumar V, Amir E, Nadler MB, Lee R, Glicksman RM

Clinical and translational radiation oncology2026

DOI: 10.1016/j.ctro.2026.101164 PMID: 42011409

The Impact of Ontario's Virtual Care Payment Model on Cancer Care: A Natural Policy Experiment.

Suleman A, Liu ZA, Sinaiko A, Prica A, Rodin D

Journal of medical Internet research2026Senior author

DOI: 10.2196/89151 PMID: 42061833

Improved survival and health care use with CAR-T vs historical care in relapsed/refractory large B-cell lymphoma.

Kordbacheh T, Chan KKW, Crump M, Ante Z, Liu N, Aminilari M, Gong IY, Bhella S, Vijenthira A, Kuruvilla J, Kridel R, Chen C, Kukreti V, Yang C, Hodgson D, Prica A, Rodin D

Blood advances2026Senior author

DOI: 10.1182/bloodadvances.2025017401 PMID: 41544221

Long-Term Risk of Cardiovascular Disease After Contemporary Left-Sided Breast Radiation Therapy.

Nakajima E, Nguyen L, Liu N, Rodin D, Amir E, Austin PC, Thavendiranathan P, Abdel-Qadir H

JAMA network open2026

DOI: 10.1001/jamanetworkopen.2026.4098 PMID: 41920543

Canadian French translation of the BREAST-Q Breast Conserving Therapy module.

Rafinejad-Farahani B, Bernardini LC, Bourque JM, Koch CA, Rodin D

Journal of patient-reported outcomes2026Senior author

DOI: 10.1186/s41687-026-01049-6 PMID: 41917649

Something wrong or missing on this profile? Suggest a correction

Danielle Rodin

Research

Latest papers

Latest funding

Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023.

Pilot Health Care Provider Education Program for BRCA1/2 Genetic Testing, Counseling, and Management in Nigeria.

Management and Outcomes for Patients With Hodgkin Lymphoma With Partial Metabolic Response After First-Line Systemic Therapy.

Association of comorbidity burden with cause-specific survival after CAR T therapy for large B-cell lymphoma.

End-of-treatment positron emission tomography/computed tomography complete remission is highly prognostic in nodal peripheral T-cell lymphoma: An Australasian-Canadian collaborative study.

The role of stereotactic body radiotherapy in oligoprogressive breast cancer: A site-specific analysis of the prospective, phase-II RADIANT trial.

The Impact of Ontario's Virtual Care Payment Model on Cancer Care: A Natural Policy Experiment.

Improved survival and health care use with CAR-T vs historical care in relapsed/refractory large B-cell lymphoma.

Long-Term Risk of Cardiovascular Disease After Contemporary Left-Sided Breast Radiation Therapy.

Canadian French translation of the BREAST-Q Breast Conserving Therapy module.

Frequent collaborators

John Kuruvilla

David Hodgson

Robert Kridel

Eileen Rakovitch

Alejandro Berlin

Mary Gospodarowicz

Rinku Sutradhar

Meredith Giuliani

Lawrence Paszat

Gary Rodin

Janet Papadakos

Sharon McGee

Eitan Amir

Jennifer Croke

Anna Dare

Ning Liu

Fei-Fei Liu

Jonathan Sussman

Robin Urquhart

Madeline Li

Lee Mozessohn

Kathy Han

Sharon Nofech-Mozes

Lillian Sung

Amit Oza

Tom Kouroukis

Michael Milosevic

Lisa Avery

Michael Yan

Jean-Michel Caudrelier

Libni Eapen

Philippe Bedard

Aisha Lofters